Trademarkia Logo

Canada

C$
vyepti
REGISTERED

on 7 Sept 2022

Last Applicant/ Owned by

H. Lundbeck A/S

Ottiliavej 9DK-2500 Valby

DK

Serial Number

2046755 filed on 19th May 2020

Registration Number

TMA1141374 registered on 7th Sept 2022

Registration expiry Date

19th May 2030

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

vyepti

Trademark usage description

vaccines for humans; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting Read More

Vienna Information


26 . 3 . 4

Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant

26 . 3 . 7

Triangular figures with one or more truncated or rounded anglesFigures triangulaires à un ou plusieurs angles coupés ou arrondis

26 . 3 . 19

Triangles with inscriptions projecting beyond one or more of the sides thereofTriangles avec inscriptions débordant un ou plusieurs côtés

26 . 3 . 5

Triangles pointing downwardsTriangles avec la pointe en bas

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 4

BlueBleu

Classification Information


Class [005]
Vaccines for humans; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; pharmaceutical preparations and substances acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; pharmaceutical preparations and substances used for the prevention, management and treatment of headaches, migraines, pain, immune diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, dyskinesia, poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes, namely medical diagnostic reagents


Classification kind code

11

Mark Details


Serial Number

2046755

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 23rd Aug 2021
Search Recorded
Submitted for opposition 20
on 23rd Aug 2021
Examiner's First Report
Submitted for opposition 223
on 23rd Aug 2021
Total Provisional Refusal
Submitted for opposition 256
on 21st Jun 2021
Notification of Possible Opposition Sent
Submitted for opposition 48
on 24th Sept 2020
Agent Changed
Submitted for opposition 257
on 20th Aug 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 20th Aug 2020
Created
Submitted for opposition 31
on 20th Aug 2020
Formalized
Submitted for opposition 30
on 19th May 2020
Filed
Submitted for opposition 228
on 19th May 2020
International Registration